Home
KLTOW

KLTOW

Klotho Neurosciences Inc. Warrant

as 10-17-2024 4:00pm EST

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.

Founded:	N/A	Country:	United States
Employees:	N/A	City:	NEW YORK
Market Cap:	N/A	IPO Year:	2022
Target Price:	N/A	AVG Volume (30 days):	N/A
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	N/A	EPS Growth:	N/A
52 Week Low/High:	N/A	Next Earning Date:	N/A
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

Latest Klotho Neurosciences Inc. Warrant News

KLTOW Breaking Stock News: Dive into KLTOW Ticker-Specific Updates for Smart Investing

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

GlobeNewswire

3 days ago

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

GlobeNewswire

18 days ago

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

All KLTOW News

Compare KLTOW vs Leading Stocks

KLTOW VS CADL

KLTOW VS ESGRP

KLTOW VS REG

KLTOW VS POLA

KLTOW VS TFINP

KLTOW VS BHFAP

KLTOW VS CWT

KLTOW VS FIACU

Share on Social Networks:

Free KLTOW Stock Widget

Embed our stock ticker widget on your website.

Stock Traders Forum

Community for stock traders to ask questions, gain insights, and learn.

Stock Alerts on Telegram

Subscribe to our Telegram channel for stock tips & insights.

Similar to KLTOW Stocks:

Disclaimer

The information presented on this page, "KLTOW Klotho Neurosciences Inc. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.